Clinical Trials Directory

Trials / Completed

CompletedNCT02163122

Cat Pilot Study - Environmental Exposure Chamber (EEC) vs. Nasal Allergen Challenge (NAC)

A Pilot Study to Compare Responses to Cat Allergen Exposure Using the Environmental Exposure Chamber (EEC) and Nasal Allergen Challenge (NAC)

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
24 (actual)
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID) · NIH
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This is a pilot trial in cat allergic participants, designed to compare allergic responses in each participant to a specific allergen by two methods of exposure. The methods of exposure to be used are: the environment exposure chamber (EEC) and nasal allergen challenge (NAC). Potential participants will be screened for evidence of cat allergy. Participants with a range of allergic sensitivities to cat allergen will be enrolled. To help ensure some breadth in the level of allergic sensitivity among participants, individuals with both high and low exposures to cat allergens in their daily lives will be enrolled.

Conditions

Interventions

TypeNameDescription
PROCEDURENasal Allergen ChallengeCat allergen (FelD1) applied directly to the nasal tissues
OTHEREnvironmental Exposure ChamberThe mobile EEC (mEEC) is a movable facility, designed with clean-room technology, used to expose subjects to aeroallergens (in this trial, the allergen FelD1 from cats) at controlled, consistent airborne levels, similar to that experienced in subjects' daily lives.
BIOLOGICALCat allergen (FelD1)

Timeline

Start date
2015-01-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2014-06-13
Last updated
2017-09-12

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02163122. Inclusion in this directory is not an endorsement.